GoAI
Get started
OneMedNet Corporation logo

OneMedNet Corporation

ONMD

NASDAQHealthcareMedical - Healthcare Information Services

Open in GoAI

Previous close

$0.60

+$0.0059 · +0.99%

Aug 21, 4:00 PM ET

Pre-market

$0.5949

−$0.0051 · -0.85%

Aug 24, 7:56 AM ET

ONMD company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

27

Expensive

Momentum

24

Weakening

Sentiment

53

Mixed

Risk resilience

27

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

OneMedNet Corporation offers advanced solutions for clinical imaging. Their core product, iRWD, is an artificial intelligence-driven platform that securely anonymizes, searches for, and organizes imaging data. This system is utilized by their extensive network of medical and academic research institutions, with the goal of fostering significant progress in medical research, new discoveries, and diagnostic techniques across the broader field of life sciences. The company's operations are based out of Eden Prairie, Minnesota.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
US
CEO
Aaron Green
Listed since
Jun 24, 2021
Employees
23

Market position

Day range

Current $0.60

52-week range

Current $0.60

Open
$0.6052
Previous close
$0.5941
Volume
185.21K
0.19× average
Average volume
989.33K
Average daily volume
Market cap
34.17M USD
Beta
1.16
Market reference 1
50-day average
$0.6617
-9.33% below average
200-day average
$0.9282
-35.36% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
48.99M USD
P/E (TTM)
-3.6×
P/B (TTM)
-9.9×
P/S (TTM)
23.47×
EV / EBITDA
-18.36×
Earnings yield
-5.72%
Free cash flow yield
-15.34%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
-68.82%
Operating margin
-695.74%
Net margin
-584.20%
Return on equity
94.47%
Return on assets
-130.22%
Return on invested capital
415.96%

Financial health

Debt / equity
-0.2×
Current ratio
0.43×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends319%-1000%-2319%-3638%Gross margin, FY2021: -10.39%Gross margin, FY2022: -31.22%Gross margin, FY2023: -12.63%Gross margin, FY2024: -43.70%Gross margin, FY2025: -37.01%Operating margin, FY2021: -248.27%Operating margin, FY2022: -669.12%Operating margin, FY2023: -671.20%Operating margin, FY2024: -1493.78%Operating margin, FY2025: -711.33%Net margin, FY2021: -269.37%Net margin, FY2022: -2641.02%Net margin, FY2023: -3308.52%Net margin, FY2024: -1575.27%Net margin, FY2025: -206.11%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 -10.39%. Gross margin FY2022 -31.22%. Gross margin FY2023 -12.63%. Gross margin FY2024 -43.70%. Gross margin FY2025 -37.01%. Operating margin FY2021 -248.27%. Operating margin FY2022 -669.12%. Operating margin FY2023 -671.20%. Operating margin FY2024 -1493.78%. Operating margin FY2025 -711.33%. Net margin FY2021 -269.37%. Net margin FY2022 -2641.02%. Net margin FY2023 -3308.52%. Net margin FY2024 -1575.27%. Net margin FY2025 -206.11%.

Income trends

Revenue

1.36M USD+111.35%

Operating income

−9.67M USD-0.65%

Net income

−2.8M USD+72.35%
Income trends across reported periods4.87M USD−9.18M USD−23.24M USD−37.29M USDRevenue, FY2021: 1.09M USDRevenue, FY2022: 1.15M USDRevenue, FY2023: 1.02M USDRevenue, FY2024: 643K USDRevenue, FY2025: 1.36M USDOperating income, FY2021: −2.71M USDOperating income, FY2022: −7.72M USDOperating income, FY2023: −6.85M USDOperating income, FY2024: −9.61M USDOperating income, FY2025: −9.67M USDNet income, FY2021: −2.94M USDNet income, FY2022: −30.45M USDNet income, FY2023: −33.78M USDNet income, FY2024: −10.13M USDNet income, FY2025: −2.8M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.09M USD. Revenue FY2022 1.15M USD. Revenue FY2023 1.02M USD. Revenue FY2024 643K USD. Revenue FY2025 1.36M USD. Operating income FY2021 −2.71M USD. Operating income FY2022 −7.72M USD. Operating income FY2023 −6.85M USD. Operating income FY2024 −9.61M USD. Operating income FY2025 −9.67M USD. Net income FY2021 −2.94M USD. Net income FY2022 −30.45M USD. Net income FY2023 −33.78M USD. Net income FY2024 −10.13M USD. Net income FY2025 −2.8M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue1.36M USD643K USD1.02M USD1.15M USD1.09M USD
Cost of goods sold1.86M USD924K USD1.15M USD1.51M USD1.21M USD
Gross profit−503K USD−281K USD−129K USD−360K USD−113.41K USD
Research and development1.52M USD1.47M USD2.07M USD1.59M USD642.77K USD
Selling, general, and administrative7.65M USD7.86M USD4.66M USD13.84M USD1.8M USD
Operating expenses9.16M USD9.32M USD6.72M USD7.36M USD2.6M USD
Interest expense67K USD147K USD11K USD403.31K USD195.38K USD
Depreciation and amortization65K USD57K USD28K USD25K USD14.47K USD
Operating income−9.67M USD−9.61M USD−6.85M USD−7.72M USD−2.71M USD
Net income−2.8M USD−10.13M USD−33.78M USD−30.45M USD−2.94M USD

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
-0.06
FY2025
Latest fiscal-year revenue
1.36M USD
FY2025 · +111.35% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend0.41-1.47-3.36-5.24FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend1.43M1.14M857.8K571.4KFY21FY22FY23FY24FY25

ONMD peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding ONMD

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
608.26K
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
221.1K
Weight
0.00%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
iShares Micro-Cap ETF logoiShares Micro-Cap ETFIWC
Market value
28.59K
Weight
0.00%
AUM
1.53B USD
Expense ratio
0.60%
Price / 1D
$198.39+1.10%
Avantis Total Equity Markets ETF 1 logoAvantis Total Equity Markets ETF 1AVTM
Market value
540.04
Weight
—
AUM
795.5M USD
Expense ratio
0.23%
Price / 1D
$55.32020.00%

Continue in GoAI

Research ONMD

research.disclaimer